Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019.
Mark W TenfordeCharisse N CummingsAlissa C O'HalloranGretchen RothrockPam Daily KirleyNisha B AldenJames MeekKimberly Yousey-HindesKyle P OpenoEvan J AndersonMaya L MonroeSue KimVal Tellez NunezMelissa McMahonChelsea McMullenSarah A KhanlianNancy L SpinaAlison MuseMaria A GaitánChristina B FelsenKrista LungEli ShiltzMelissa SuttonAnn ThomasH Keipp TalbotWilliam SchaffnerAndrea PriceRyan ChatelainCarrie ReedShikha GargPublished in: Open forum infectious diseases (2022)
From surveillance data of patients hospitalized with laboratory-confirmed influenza in the United States during the 2015-2016 through 2018-2019 seasons, initiation of antiviral treatment increased from 86% to 94%, with increases seen across all age groups. However, 62% started therapy ≥3 days after illness onset, driven by late presentation to care.